Now that the management own a bigger chunk of the company after April's Cap raise at 1.7c, they must want a better outcome than that imo.
We have been promised progress repeatedly by the management. I was hoping that the confidence that was shown in underwriting the (underwhelming) cap raise and the timing of it indicated that the promises were about to start coming true. The Podcast almost said as much. Phrases like "Potentially transformational", and "step change" were used.
What does a 2c bid mean? a $1mm profit for the quarter and a PE of 10x on a tech company in this space? Just seems a bit light to me.....
Personally I think that the current MC can hold on a lacklustre improvement in Sep quarter revenue, but if the next quarter is shabby, the management and the rest of us have probably lost our dough.....
- Forums
- ASX - By Stock
- ADS
- Ann: Investor Webinar Presentation
Ann: Investor Webinar Presentation, page-21
Featured News
Add ADS (ASX) to my watchlist
|
|||||
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.749M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
ADS (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online